Imago BioSciences, Inc. Proceeds from Issuance Initial Public Offering
Imago BioSciences, Inc. reported Proceeds from Issuance Initial Public Offering of $143.74 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2022-11-09
- 2021-09-30: Proceeds from Issuance Initial Public Offering 9 month $143.74M.
| Period end | Proceeds from Issuance Initial Public Offering 9 month |
|---|---|
| 2021-09-30 | $143.74M 10-Q · filed 2022-11-09 |